Trial Profile
Golimumab: A UK Two-part Observational Study Of Its Utilisation And Impact in Patients with Ankylosing Spondylitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 15 Mar 2016 New trial record